The findings of a new preclinical study in pulmonary sarcoidosis are lending support to the therapeutic potential of efzofitimod, a treatment candidate from Atyr Pharma now being tested in a Phase […] The post Study backs efzofitimod as potential pulmonary sarcoidosis treatment appeared first on Sarcoidosis News.
